Insight Molecular Diagnostics Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Insight Molecular Diagnostics Inc. on April 30, 2026. The filing addresses a clerical error in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, which was originally filed on March 26, 2026.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a corrective filing regarding corporate governance documents and does not contain financial performance data.
Material Changes
The Company corrected an error in Exhibit 3.5 of its previously filed Form 10-K. The original exhibit inadvertently included provisions related to shareholder voting that were not part of the Third Amended and Restated Bylaws. The Company has filed the correct copy of the Bylaws as Exhibit 3.1. No other disclosures in the Form 10-K are changed.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the correction of the clerical error.
Key Facts for Investor Verification
- Verify the corrected Third Amended and Restated Bylaws attached as Exhibit 3.1 to this Form 8-K.
- Confirm that the erroneous shareholder voting provisions previously included in the Form 10-K are not part of the official Bylaws.
- Note that this filing does not alter any financial or operational disclosures made in the March 26, 2026 Form 10-K.